Inherited Retinal Diseases Clinical Trials
Take Part In Exploring Potential Treatment Options For Inherited Retinal Diseases
What Are Inherited Retinal Diseases?
Inherited retinal diseases (IRDs) are a group of genetic conditions that affect the retina, the light-sensitive tissue at the back of the eye that is essential for vision. These conditions are caused by inherited gene variations that can affect how retinal cells develop, function, or survive over time.
IRDs vary widely in how they affect vision. Depending on the specific condition, individuals may experience changes in night vision, peripheral vision, central vision, color vision, or overall visual function. Many inherited retinal diseases are progressive, meaning vision changes may develop gradually over time.
Common Types of Inherited Retinal Diseases
Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of inherited retinal disorders that typically affect the retina’s light-sensing cells. Symptoms often begin with difficulty seeing in low-light environments and may progress to reduced peripheral vision over time.
Stargardt Disease
Stargardt disease is an inherited macular disorder that primarily affects central vision. It often develops during childhood, adolescence, or early adulthood and can make activities such as reading or recognizing details more challenging.
Leber Congenital Amaurosis (LCA)
Leber congenital amaurosis is a rare inherited retinal disease that typically causes significant visual impairment beginning in infancy or early childhood. It is one of several genetic retinal conditions currently being studied through ongoing research efforts.
How You Can Help Advance Inherited Retinal Disease Research
Inherited retinal disease clinical trials evaluate investigational approaches aimed at better understanding the genetic, cellular, and retinal changes associated with these conditions.
Research may assess visual function, retinal structure, disease progression, genetic markers, and other measures used to study inherited retinal diseases. Some studies focus on specific conditions such as retinitis pigmentosa, Stargardt disease, or Leber congenital amaurosis, while others evaluate broader groups of genetic retinal disorders.
At Equity Medical, these studies are conducted by experienced physicians and clinical research professionals following structured research protocols designed to support accurate and consistent evaluation throughout the study process.
You May Be Eligible If You:
Submitting your information does not enroll you in a study. A member of our team will follow up to review your history and determine whether a current inherited retinal disease clinical trial may be a good fit.
Why Join an Inherited Retinal Disease Clinical Trial
Why Participants Choose Equity Medical
Because many inherited retinal diseases are rare, research plays an important role in expanding scientific understanding of these conditions. Participation helps researchers continue studying genetic retinal disorders and may contribute to future advances in how these diseases are evaluated and understood.
At Equity Medical, participants are supported by experienced physicians, study coordinators, and research professionals who provide clear guidance throughout the study process. Our commitment to participant safety, ethical research practices, and data integrity helps ensure studies are conducted responsibly and with careful attention to quality.
Our Locations
Equity Medical offers access to clinical trials across multiple locations, helping individuals find research opportunities closer to home.
